GRP receptor silencing reduced Mycn/FAK levels in BE (2)-C NB cells; FAK overexpression favored cell growth in SK-N-SH NB cells; and FAK blockers (Y15) inhibited the NB cell growth and metastasis promoted by GRP [30]. The gene discussed is MYCN; the disease is neuroblastoma.